Skip to main content
OpenTrials

Clinical trial condition

Chronic Disease

Explore clinical trials studying Chronic Disease. Study availability and eligibility vary by location and protocol.

13,138 public trials 1,630 recruiting studies
Refine in advanced search Browse all conditions

Chronic Disease trial results

Recruiting

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

NCT06542250

Conditions
B-cell Malignancies, Chronic Disease, Disease Attributes, +19 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site Hackensack, New Jersey, United States
View all 31 locations
View Trial Details
Recruiting

REGEND001 Autologous Basal Layer Stem Cell Transplantation for Chronic Obstructive Pulmonary Disease (COPD): A Translational Application Study

NCT06946953

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Ruijin Hospital Hainan Branch, Shanghai Jiao Tong University School of Medicine Qionghai, Hainan, China
  • Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Recruiting

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

NCT06920004

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, CIDP, +14 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Samir Macwan, M.D., Inc. Rancho Mirage, California, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 82 locations
View Trial Details
Recruiting

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

NCT07091019

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia - Chronic Phase, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Stockton Hematology Oncology Medical Group Inc Stockton, California, United States
  • Lundquist Inst BioMed at Harbor Torrance, California, United States
  • Stamford Hospital Stamford, Connecticut, United States
View all 17 locations
View Trial Details
Recruiting

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

NCT07205315

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +31 more
Locations
  • Zhengzhou Yihe Hospital Zhengzhou, Henan, China
  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details

Related conditions